Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024
Investors interested in listening to the conference call may do so by dialing (800) 715-9871 for domestic callers or (646) 307-1963 for international callers and providing access code 7168007. A live and archived webcast of the event will be available in the "Investor Relations" section of the Ceribell website at https://investors.ceribell.com/.
About
Ceribell is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Ceribell System is an AI-powered, rapidly deployable point-of-care electroencephalography ("EEG") platform designed to address the unmet needs of patients in the acute care setting. The company is headquartered in
Investor Contact
Investors@ceribell.com
Media Contact
Press@ceribell.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ceribell-to-report-third-quarter-2024-financial-results-on-november-12-2024-302290488.html
SOURCE